RNA modification-mediated mRNA translation regulation in liver cancer: mechanisms and clinical perspectives
- PMID: 38243019
- DOI: 10.1038/s41575-023-00884-y
RNA modification-mediated mRNA translation regulation in liver cancer: mechanisms and clinical perspectives
Abstract
Malignant liver cancer is characterized by rapid tumour progression and a high mortality rate, whereas the molecular mechanisms underlying liver cancer initiation and progression are still poorly understood. The dynamic and reversible RNA modifications have crucial functions in gene expression regulation by modulating RNA processing and mRNA translation. Emerging evidence has revealed that alterations in RNA modifications facilitate the selective translation of oncogenic transcripts and promote the diverse tumorigenic processes of liver cancer. In this Review, we first highlight the current progress on the functions and mechanisms underlying RNA modifications in the regulation of mRNA translation and then summarize the exciting discoveries on aberrant RNA modification-mediated mRNA translation in the regulation of tumour initiation, metastasis, metabolism, tumour microenvironment, and drug and radiotherapy resistance in liver cancer. Finally, we discuss the diagnostic and therapeutic potentials of targeting RNA modifications and mRNA translation for the clinical management of liver cancer.
© 2024. Springer Nature Limited.
Similar articles
-
Translational control of aberrant stress responses as a hallmark of cancer.J Pathol. 2018 Apr;244(5):650-666. doi: 10.1002/path.5030. Epub 2018 Feb 20. J Pathol. 2018. PMID: 29293271 Review.
-
The plasticity of mRNA translation during cancer progression and therapy resistance.Nat Rev Cancer. 2021 Sep;21(9):558-577. doi: 10.1038/s41568-021-00380-y. Epub 2021 Aug 2. Nat Rev Cancer. 2021. PMID: 34341537 Review.
-
m6 A RNA methylation: from mechanisms to therapeutic potential.EMBO J. 2021 Feb 1;40(3):e105977. doi: 10.15252/embj.2020105977. Epub 2021 Jan 20. EMBO J. 2021. PMID: 33470439 Free PMC article. Review.
-
Surmounting cancer drug resistance: New insights from the perspective of N6-methyladenosine RNA modification.Drug Resist Updat. 2020 Dec;53:100720. doi: 10.1016/j.drup.2020.100720. Epub 2020 Aug 20. Drug Resist Updat. 2020. PMID: 32892147 Review.
-
Emerging functions of tRNA modifications in mRNA translation and diseases.J Genet Genomics. 2023 Apr;50(4):223-232. doi: 10.1016/j.jgg.2022.10.002. Epub 2022 Oct 26. J Genet Genomics. 2023. PMID: 36309201 Review.
Cited by
-
RNA chemistry and therapeutics.Nat Rev Drug Discov. 2025 Jul 14. doi: 10.1038/s41573-025-01237-x. Online ahead of print. Nat Rev Drug Discov. 2025. PMID: 40659813 Review.
-
Writers, readers, and erasers RNA modifications and drug resistance in cancer.Mol Cancer. 2024 Aug 30;23(1):178. doi: 10.1186/s12943-024-02089-6. Mol Cancer. 2024. PMID: 39215288 Free PMC article. Review.
-
Progress and prospects of mRNA-based drugs in pre-clinical and clinical applications.Signal Transduct Target Ther. 2024 Nov 14;9(1):322. doi: 10.1038/s41392-024-02002-z. Signal Transduct Target Ther. 2024. PMID: 39543114 Free PMC article. Review.
-
On the Quest for Biomarkers: A Comprehensive Analysis of Modified Nucleosides in Ovarian Cancer Cell Lines.Cells. 2025 Apr 22;14(9):626. doi: 10.3390/cells14090626. Cells. 2025. PMID: 40358150 Free PMC article.
-
Polychlorinated Biphenyl Exposure Alters tRNA Transcriptome in High-Fat Diet-Fed Mouse Liver.Noncoding RNA. 2025 May 22;11(3):41. doi: 10.3390/ncrna11030041. Noncoding RNA. 2025. PMID: 40559619 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical